Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China
· Delayed Price · Currency is CNY 10.95
-0.13 (-1.17%)
Apr 29, 2026, 3:10 PM CST
Aier Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 3,371 | 3,240 | 3,556 | 3,359 | 2,524 | 2,323 | Upgrade
|
| Depreciation & Amortization | 1,748 | 1,748 | 1,594 | 1,347 | 1,166 | 951.72 | Upgrade
|
| Other Amortization | 487.56 | 487.56 | 352.71 | 318.3 | 224.17 | 173.07 | Upgrade
|
| Loss (Gain) From Sale of Assets | -9.82 | -9.82 | -4.27 | -0.71 | 1.25 | -0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 164.18 | 164.18 | 194.52 | 389.72 | 100.34 | 220.94 | Upgrade
|
| Loss (Gain) From Sale of Investments | -166.53 | -166.53 | -547.62 | 32.9 | 315.49 | 343.61 | Upgrade
|
| Provision & Write-off of Bad Debts | 125.31 | 125.31 | 116.31 | 107.44 | 77.27 | 97.89 | Upgrade
|
| Other Operating Activities | 201.43 | 444.83 | 441.84 | 443.31 | 203.62 | 234.42 | Upgrade
|
| Change in Accounts Receivable | 115.22 | 115.22 | -40.75 | -264.53 | -68.21 | -109.44 | Upgrade
|
| Change in Inventory | 3.54 | 3.54 | -85.87 | -168.65 | -159.47 | -37.58 | Upgrade
|
| Change in Accounts Payable | -239.9 | -239.9 | -877.11 | 136.05 | -48.99 | -206.86 | Upgrade
|
| Change in Other Net Operating Assets | 46 | 46 | 82.07 | 145.39 | 228.44 | 126.8 | Upgrade
|
| Operating Cash Flow | 5,860 | 5,973 | 4,882 | 5,872 | 4,491 | 4,084 | Upgrade
|
| Operating Cash Flow Growth | 8.29% | 22.35% | -16.86% | 30.76% | 9.96% | 22.15% | Upgrade
|
| Capital Expenditures | -1,969 | -2,093 | -1,830 | -1,460 | -1,388 | -1,494 | Upgrade
|
| Sale of Property, Plant & Equipment | 7.82 | 5.83 | 5.56 | 5.55 | 7.81 | 6.37 | Upgrade
|
| Cash Acquisitions | -910.28 | -621.5 | -1,966 | -1,586 | -1,126 | -945.53 | Upgrade
|
| Divestitures | - | - | - | - | 0.18 | - | Upgrade
|
| Investment in Securities | -475.69 | -443.15 | 729.12 | -305.88 | -795.67 | -250.32 | Upgrade
|
| Other Investing Activities | 58.14 | 55.54 | 213.25 | 41.75 | 42.4 | 169.16 | Upgrade
|
| Investing Cash Flow | -3,289 | -3,096 | -2,848 | -3,304 | -3,260 | -2,514 | Upgrade
|
| Long-Term Debt Issued | - | 1,636 | 1,506 | 863.31 | 438.21 | 720.32 | Upgrade
|
| Long-Term Debt Repaid | - | -2,644 | -1,870 | -1,422 | -2,350 | -1,170 | Upgrade
|
| Net Debt Issued (Repaid) | -778.43 | -1,008 | -364.64 | -559.03 | -1,912 | -449.79 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 3,852 | 1,296 | Upgrade
|
| Repurchase of Common Stock | -38.47 | -38.47 | -46.36 | -576.16 | -5.1 | -3.18 | Upgrade
|
| Common Dividends Paid | -2,262 | -1,525 | -1,419 | -746.9 | -672.56 | -662.5 | Upgrade
|
| Other Financing Activities | -525.33 | -380.38 | -903.55 | -627.63 | -872.55 | -420.08 | Upgrade
|
| Financing Cash Flow | -3,604 | -2,952 | -2,734 | -2,510 | 390.43 | -239.62 | Upgrade
|
| Foreign Exchange Rate Adjustments | -31.26 | -5.97 | -23.44 | 34.84 | 21.71 | 10.39 | Upgrade
|
| Net Cash Flow | -1,065 | -81.1 | -723.81 | 92.57 | 1,643 | 1,340 | Upgrade
|
| Free Cash Flow | 3,891 | 3,880 | 3,052 | 4,412 | 3,102 | 2,590 | Upgrade
|
| Free Cash Flow Growth | 9.10% | 27.15% | -30.84% | 42.22% | 19.79% | 5.72% | Upgrade
|
| Free Cash Flow Margin | 17.12% | 17.36% | 14.54% | 21.66% | 19.26% | 17.27% | Upgrade
|
| Free Cash Flow Per Share | 0.42 | 0.42 | 0.33 | 0.48 | 0.34 | 0.29 | Upgrade
|
| Cash Income Tax Paid | 1,276 | 1,136 | 1,152 | 1,167 | 1,052 | 1,061 | Upgrade
|
| Levered Free Cash Flow | 3,172 | 4,129 | 2,580 | 3,107 | 2,611 | 3,045 | Upgrade
|
| Unlevered Free Cash Flow | 3,336 | 4,298 | 2,740 | 3,229 | 2,722 | 3,148 | Upgrade
|
| Change in Working Capital | -60.75 | -60.75 | -822.07 | -125.13 | -121.92 | -260.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.